Avidity Partners Management LP Lantheus Holdings, Inc. Transaction History

Avidity Partners Management LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$58.87 - $83.05 $11.2 Million - $15.8 Million	-190,000 Reduced 39.58%	290,000 $23.3 Million
Q1 2024 May 15, 2024	BUY	$51.07 - $68.26 $5.11 Million - $6.83 Million	100,000 Added 26.32%	480,000 $29.9 Million
Q4 2023 Feb 14, 2024	SELL	$55.6 - $77.89 $9.92 Million - $13.9 Million	-178,400 Reduced 31.95%	380,000 $23.6 Million
Q3 2023 Nov 14, 2023	BUY	$60.27 - $90.75 $18.9 Million - $28.4 Million	313,300 Added 127.83%	558,400 $38.8 Million
Q2 2023 Aug 14, 2023	BUY	$82.41 - $99.65 $20.2 Million - $24.4 Million	245,100 New	245,100 $20.6 Million

540

68M

679K

423K

Ticker LNTH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 68,741,904
Market Cap $6.14B
Description
Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...

Get notified when there are updates to the investment portfolio of Avidity Partners Management LP, based on Form 13F filings with the SEC.

Stay updated on Avidity Partners Management LP with notifications on news.